Statements (54)
Predicate | Object |
---|---|
gptkbp:instanceOf |
Research organization
|
gptkbp:aimsTo |
improve patient outcomes
advance scientific knowledge develop innovative therapies |
gptkbp:collaboratesWith |
academic institutions
|
gptkbp:conducts |
clinical studies
preclinical studies |
gptkbp:contributedTo |
mental health research
|
gptkbp:develops |
medications for mental health disorders
|
gptkbp:engagesIn |
drug development
biomedical research drug_discovery |
gptkbp:focusesOn |
pharmaceutical research
|
gptkbp:foundedIn |
2009
|
gptkbp:hasCollaborationsWith |
government agencies
pharmaceutical companies research institutions |
gptkbp:hasEmployees |
researchers
scientists clinical trial coordinators |
gptkbp:hasFilm |
be a leader in neuroscience research
|
gptkbp:hasImpactOn |
healthcare policies
clinical_practices |
gptkbp:hasMission |
enhance mental health
|
gptkbp:hasPart |
laboratories
research facilities clinical research units |
https://www.w3.org/2000/01/rdf-schema#label |
Lundbeck Research USA
|
gptkbp:isInvolvedIn |
community outreach
educational initiatives patient advocacy |
gptkbp:isKnownFor |
research in Alzheimer's disease
research in anxiety disorders research in depression research in epilepsy research in schizophrenia |
gptkbp:isLocatedIn |
gptkb:New_Jersey
|
gptkbp:isPartOf |
global research network
|
gptkbp:isRecognizedBy |
regulatory agencies
scientific community healthcare_professionals |
gptkbp:isSupportedBy |
grants
partnerships Lundbeck_A/S_funding |
gptkbp:location |
gptkb:USA
|
gptkbp:offers |
clinical trials
|
gptkbp:parentCompany |
gptkb:Lundbeck_A/S
|
gptkbp:participatesIn |
international conferences
|
gptkbp:partOf |
gptkb:Lundbeck
|
gptkbp:receivesFundingFrom |
gptkb:Lundbeck_A/S
|
gptkbp:specializesIn |
neurology
|
gptkbp:utilizes |
advanced technologies
biomarkers data analytics |